Aggressive Treatment and Bone Marrow Transplant Help MidState Patient Beat Leukemia

Print icon

For months Tracy Seguljic hadn’t been feeling well.  She had recently lost her husband to glioblastoma—an aggressive form of brain cancer—and believed she was just suffering from exhaustion, brought on by her grief and the months spent caring for her husband and two teenage sons.

After experiencing shortness of breath, Seguljic, a Berlin resident, went to the emergency department at MidState Medical Center where a bone marrow biopsy confirmed that she had acute myeloid leukemia (AML).

“I was told to prepare for a month in the hospital.  But at no point did I ever think I was going to die,” Seguljic said.

From the emergency department, oncologist Dr. Susan Alsamarai quickly began to develop a strategy for Seguljic’s care which included an aggressive form of chemotherapy and a bone marrow transplant in partnership with Memorial Sloan Kettering Cancer Center.

“We needed to get things started quickly. We worked with pathology to get the results so we would know what the right course of treatment should be. We needed to know what form of leukemia she had and what mutations she might have,” said Dr. Alsamarai.

Seguljic had a mutation known as FLT3 which makes the cancer even more aggressive.  Luckily for Seguljic her treatment worked, and within two months her cancer went into remission.  The next step was for Seguljic to have a bone marrow transplant. Thanks to the Hartford Healthcare Cancer Institute’s membership in the Memorial Sloan Kettering (MSK) Cancer Alliance, Seguljic’s transplant was seamlessly coordinated by her providers at MidState and the world renowned specialists at MSK. 

“It was very smooth getting her [to MSK in New York City] and expediting the transplant.  This was 2015 and we had just begun our relationship with MSK. It was a good prototype of how we should carry out this relationship,” said Alsamarai.

Seguljic’s transplant, made possible through a marrow donation from her sister, was a success.  Four years into the partnership with MSK, the Cancer Institute now employs a bone marrow coordinator who facilitates transplants like Seguljic’ s.

Seguljic credits the quick thinking by the team at MidState and the expertise of MSK in helping her beat leukemia.  But, it’s her faith that has guided her emotionally through some pretty dark days, she said.

“This is just a bump in the road.  You lean on God and don’t sweat the little things,” she said.

Learn more about the Memorial Sloan Kettering Cancer Alliance and clinical trials offered through the Hartford HealthCare Cancer Institute.


What's New

Pancreatic Cancer

Free Pancreatic Care Webinar June 11

The fourth leading cause of cancer death in both men and women, pancreatic cancer, is an aggressive form of the disease that often exhibits few symptoms until it is advanced. Approximately 57,000 Americans will be diagnosed with it this year, according to the American Cancer Society. About 47,000 will die...

Jeffrey A. Flaks

A Message From Hartford HealthCare CEO Jeffrey Flaks

With the concerns about coronavirus and COVID-19, I want to assure you that Hartford HealthCare is doing everything possible to protect the safety and well-being of the people and the communities we serve, and our team of healthcare providers. Our goal is to be ready and prepared for whatever is...

Quite Smoking

Trying to Quit Smoking? Here’s Some Help

Editor’s note: Initial studies have shown that if you smoke and get COVID-19, you’re 14 times more likely than nonsmokers to require intensive treatment. If you’ve considered stopping smoking, now is a good time. By Ellen Anderson Dornelas, PhD Director, Cancer Care Delivery and Disparities Research Hartford Healthcare Cancer Institute...

Pancreatic Cancer Recovery

How to Manage Pancreatic Cancer Treatment’s Side Effects

A pancreatic cancer survivor is any person who is actively facing pancreatic cancer or has faced it at some point. It could be someone who has completed treatment or a patient actively receiving chemotherapy for a limited or long-term management of their disease. Patients treated with chemotherapy experience a variety...

Breast Cancer Awareness

The New Normal for Breast Cancer Survivors

The word “patient” stems from the Latin word patiens, meaning sufferer. Until recently, a diagnosis of cancer conveyed a sense of victimhood and loss of control, hence labels such as “cancer patient” or “cancer victim.” Despite good intentions, these terms left those with a cancer diagnosis feeling isolated and somehow...